socalTechnews
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Wednesday, November 29, 2006

    Kalypsys Raises $100M
    San Diego-based Kalypsys, a firm developing small molecule pharmaceuticals, said today that it has raised $100M in a Series C financing. The funding was led by Tavistock Life Sciences, which contributed $89M to the round. Other investors in the round included Sprout Group, CMEA Ventures, and KT Venture Group. The new round of funding brings the company's total raised to $172M. Kalypsys is developing compounds aimed at metabolic disorders, pain/inflammation, and oncology.
    posted on Wednesday, November 29, 2006 (Link to more information)

    Related companies:
    Kalypsys

    Related stories:
    > Kalypsys Completes $29M Series B
    > Kalypsys Appoints CEO
    > Demand Media Reportedly Raises $100M
    > Demand Media Raises $100M
    > Homestore Gets $100M From Elevation Partners

    RSS subscri be via emailEmail


    Previous news:

     Monday, October 6, 2008
    Friday, October 3, 2008
    Thursday, October 2, 2008
    Wednesday, October 1, 2008
    Tuesday, September 30, 2008